REED JOHN C 内部人交易：近期 SEC Form 4 交易
过去 18 个月，REED JOHN C（CIK 1181561）在 2 家公司共报告 17 笔 SEC Form 4 内部人交易（最近一笔 2026-08-18）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-08-18 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | 董事 | 买入 | 647 | $0 |
| 2026-05-04 | JOHNSON & JOHNSON (JNJ) | EVP, Innovative Medicine, R&D | 买入 | 25,255 | $0 |
| 2026-05-04 | JOHNSON & JOHNSON (JNJ) | EVP, Innovative Medicine, R&D | 卖出 | 11,002 | $2.5M |
| 2026-02-18 | JOHNSON & JOHNSON (JNJ) | EVP, Innovative Medicine, R&D | 买入 | 1,349 | $0 |
| 2026-02-18 | JOHNSON & JOHNSON (JNJ) | EVP, Innovative Medicine, R&D | 卖出 | 385 | $93,728 |
| 2026-02-18 | JOHNSON & JOHNSON (JNJ) | EVP, Innovative Medicine, R&D | 买入 | 1,847 | $0 |
| 2026-02-18 | JOHNSON & JOHNSON (JNJ) | EVP, Innovative Medicine, R&D | 卖出 | 528 | $128,542 |
| 2026-02-18 | JOHNSON & JOHNSON (JNJ) | EVP, Innovative Medicine, R&D | 买入 | 21,721 | $3.4M |
| 2026-02-18 | JOHNSON & JOHNSON (JNJ) | EVP, Innovative Medicine, R&D | 卖出 | 21,721 | $5.3M |
| 2026-02-18 | JOHNSON & JOHNSON (JNJ) | EVP, Innovative Medicine, R&D | 买入 | 29,927 | $4.7M |
| 2026-02-18 | JOHNSON & JOHNSON (JNJ) | EVP, Innovative Medicine, R&D | 卖出 | 29,927 | $7.3M |
| 2026-02-18 | JOHNSON & JOHNSON (JNJ) | EVP, Innovative Medicine, R&D | 卖出 | 2,283 | $554,769 |
| 2025-10-20 | JOHNSON & JOHNSON (JNJ) | EVP, Innovative Medicine, R&D | 买入 | 21,721 | $3.4M |
| 2025-10-20 | JOHNSON & JOHNSON (JNJ) | EVP, Innovative Medicine, R&D | 卖出 | 21,721 | $4.2M |
| 2025-07-18 | JOHNSON & JOHNSON (JNJ) | EVP, Innovative Medicine, R&D | 卖出 | 19,137 | $3.1M |
| 2025-05-05 | JOHNSON & JOHNSON (JNJ) | EVP, Innovative Medicine, R&D | 卖出 | 11,002 | $1.7M |
| 2025-05-05 | JOHNSON & JOHNSON (JNJ) | EVP, Innovative Medicine, R&D | 买入 | 25,255 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-08-18